Back

Multiple myeloma and al cardiac amyloidosis: the predictive role of HFA/ICOS risk score and other parameters

20 June 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Striking the balance: cardiac risks and outcomes in haematopoietic stem cell transplantation, multiple myeloma and AL-amyloidosis Stratification, Prevention and Monitoring CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speakers

Photo
Associate Professor Giuseppina Novo

University of Palermo, Palermo (Italy)

Photo
Doctor Daniela Di Lisi

University Hospital Paolo Giaccone, Palermo (Italy)

6 More presentations in this session

Presentation thumbnail
Predicting cardiovascular events in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study
Doctor B. Sibilia (Paris, FR)
Abstract Slides
Presentation thumbnail
Sex differences in cardiovascular complications after allogeneic hematopoietic stem cell transplantation
Doctor T. Goncalves (Toronto, CA)
Abstract Slides
Presentation thumbnail
Cardiovascular events in patients diagnosed with light chain amyloidosis in the USA: a real-world analysis utilizing electronic health records
Doctor J. Catini (Boston, US)
Abstract Slides
Presentation thumbnail
Mortality & inpatient hospitalizations amongst patients with cardiac light-chain amyloidosis: results from a US administrative claims database
Doctor J. Catini (Boston, US)
Abstract Slides
Presentation thumbnail
Progression of pulmonary arterial systolic pressure after chemotherapy is a poor prognostic factor in patients with multiple myeloma
Doctor H. Yoon (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Striking the balance: cardiac risks and outcomes in haematopoietic stem cell transplantation, multiple myeloma and AL-amyloidosis

The Event

Event poster

ESC Cardio-Oncology 2025

20 June 2025 10:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources